Form 4: Precigen Director Kirk's RSU Vesting Adds 143,678 Shares

Randal J. Kirk, a Director and 10% owner of Precigen, Inc., acquired 143,678 shares of common stock through the vesting of restricted stock units.

Summary

• Randal J. Kirk, a Director and 10% owner of Precigen, Inc. (PGEN), acquired 143,678 shares of common stock.
• This acquisition resulted from the vesting of restricted stock units (RSUs) granted on March 13, 2025.
• The RSUs vested in their entirety on March 13, 2026, the one-year anniversary of the grant date.
• The transaction price for these shares was $0, as is typical for RSU vesting.
• Following this transaction, Mr. Kirk's indirect beneficial ownership through various entities remains substantial, including 81,781,816 shares held by R.J. Kirk DOT.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. It's a routine compensation matter, but the increased insider ownership, even through vesting, generally aligns management interests with shareholders, which is a positive signal.

Positives

• Increased direct ownership by a key insider (Director and 10% owner) through RSU vesting, aligning management interests with shareholders.
• The vesting of RSUs indicates the fulfillment of performance or time-based conditions set at the grant date.

Future Outlook

The filing does not contain specific forward-looking statements or guidance, as it is a report of a past insider transaction.

Industry Context

StockSavvy.ai notes that routine insider filings like Form 4, especially those related to RSU vesting, are common across industries. While not indicative of new strategic moves, they provide transparency into executive compensation and ownership alignment. For biotech companies like Precigen, insider ownership can signal confidence in long-term pipeline development, though this specific filing is a standard compensation event.

Related Party Transactions

• Randal J. Kirk controls various entities (e.g., R.J. Kirk DOT, JPK 2008 LLC, Third Security, LLC) that hold significant shares of Precigen, Inc. common stock. He disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein.

Stakeholder Impact

• Shareholders: Increased alignment of a significant insider's interests with long-term shareholder value due to increased ownership.
• Management/Employees: The vesting of RSUs is a standard component of executive compensation, reflecting the fulfillment of employment terms.

Key Dates

Recommendation

This Form 4 filing reports a routine insider transaction related to RSU vesting and does not provide new fundamental information to warrant a change in investment thesis. It confirms a director's continued significant ownership, which is generally a neutral to slightly positive signal for long-term alignment, but not a catalyst for a 'buy' or 'sell' decision.

Keywords

Precigen, PGEN, Randal J. Kirk, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Beneficial Ownership, Director, 10% Owner